Janney Montgomery Scott’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64M Buy
25,373
+202
+0.8% +$14.2K ﹤0.01% 1381
2025
Q4
$1.69M Buy
25,171
+874
+4% +$58.8K ﹤0.01% 1432
2025
Q3
$1.78M Sell
24,297
-171
-0.7% -$11.4K ﹤0.01% 1376
2025
Q2
$1.27M Sell
24,468
-269,655
-92% -$15.3M ﹤0.01% 1438
2025
Q1
$18.8M Buy
294,123
+6,392
+2% +$371K 0.05% 349
2024
Q4
$13.8M Buy
287,731
+251,711
+699% +$12.9M 0.04% 443
2024
Q3
$2.06M Buy
36,020
+9,995
+38% +$573K 0.01% 1130
2024
Q2
$1.36M Buy
26,025
+9,571
+58% +$420K ﹤0.01% 1288
2024
Q1
$669K Buy
16,454
+3,666
+29% +$137K ﹤0.01% 1762
2023
Q4
$473K Buy
+12,788
New +$482K ﹤0.01% 1947
2023
Q1
Sell
-8,290
Closed -$472K 2628
2022
Q4
$472K Buy
+8,290
New +$424K ﹤0.01% 1809
2021
Q4
Sell
-5,585
Closed -$227K 2391
2021
Q3
$227K Sell
5,585
-7,405
-57% -$310K ﹤0.01% 2099
2021
Q2
$590K Sell
12,990
-7,173
-36% -$317K ﹤0.01% 1542
2021
Q1
$841K Buy
20,163
+5,866
+41% +$268K ﹤0.01% 1287
2020
Q4
$611K Buy
+14,297
New +$514K ﹤0.01% 1447
2019
Q4
Sell
-45,203
Closed -$701K 2102
2019
Q3
$701K Sell
45,203
-18,089
-29% -$298K 0.01% 1196
2019
Q2
$1.09M Sell
63,292
-3,631
-5% -$58.6K 0.01% 1006
2019
Q1
$1.08M Sell
66,923
-1,474
-2% -$23.9K 0.01% 979
2018
Q4
$1M Sell
68,397
-4,552
-6% -$72.6K 0.01% 927
2018
Q3
$1.32M Sell
72,949
-1,038
-1% -$18.2K 0.01% 875
2018
Q2
$1.25M Sell
73,987
-830
-1% -$15.7K 0.01% 879
2018
Q1
$1.47M Sell
74,817
-2,119
-3% -$41K 0.01% 795
2017
Q4
$1.56M Sell
76,936
-7,437
-9% -$137K 0.02% 758
2017
Q3
$1.47M Sell
84,373
-3,516
-4% -$47.6K 0.02% 750
2017
Q2
$1.13M Buy
87,889
+3,015
+4% +$40.3K 0.01% 817
2017
Q1
$1.1M Buy
84,874
+877
+1% +$11.1K 0.01% 800
2016
Q4
$830K Sell
83,997
-82,767
-50% -$907K 0.01% 865
2016
Q3
$2.02M Buy
+166,764
New +$1.7M 0.04% 435
2016
Q2
Sell
-174,985
Closed -$1.66M 901
2016
Q1
$1.66M Buy
174,985
+36,830
+27% +$347K 0.04% 376
2015
Q4
$2.39M Buy
138,155
+17,256
+14% +$275K 0.06% 299
2015
Q3
$1.62M Buy
120,899
+9,013
+8% +$181K 0.05% 382
2015
Q2
$2.53M Sell
111,886
-15,426
-12% -$271K 0.05% 422
2015
Q1
$1.82M Sell
127,312
-28,008
-18% -$404K 0.03% 613
2014
Q4
$1.5M Sell
155,320
-2,905
-2% -$25.8K 0.03% 672
2014
Q3
$1.44M Buy
158,225
+1,055
+0.7% +$10K 0.03% 663
2014
Q2
$1.55M Buy
157,170
+42,929
+38% +$364K 0.03% 618
2014
Q1
$1.45M Sell
114,241
-3,811
-3% -$56.6K 0.04% 588
2013
Q4
$1.77M Sell
118,052
-17,353
-13% -$223K 0.05% 479
2013
Q3
$1.49M Buy
+135,405
New +$1.13M 0.04% 491

Other funds holding HALO

Janney Montgomery Scott's HALO Position: Q1 2026 in Review

Janney Montgomery Scott increased its Halozyme (HALO) stake by 0.8% in Q1 2026, buying an estimated $14.2K and bringing the position to 25,373 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

Janney Montgomery Scott first reported a position in HALO in Q3 2013 and has held it in 39 quarters since. The position peaked at $18.8M in Q1 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Janney Montgomery Scott held 25,373 shares of Halozyme worth $1.64M as of Q1 2026.
  • Janney Montgomery Scott bought 202 Halozyme shares in Q1 2026, an estimated $14.2K.
  • Halozyme made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #1381 holding.
  • Janney Montgomery Scott first reported a position in Halozyme in Q3 2013 and has held it in 39 quarters since.
  • Janney Montgomery Scott's Halozyme position peaked at $18.8M in Q1 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.